A detailed history of Deutsche Bank Ag\ transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 4,437,602 shares of APLT stock, worth $3.91 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,437,602
Previous 2,343,483 89.36%
Holding current value
$3.91 Million
Previous $10.9 Million 244.65%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.35 - $8.5 $9.11 Million - $17.8 Million
2,094,119 Added 89.36%
4,437,602 $37.7 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $6.95 Million - $11 Million
1,721,256 Added 276.63%
2,343,483 $10.9 Million
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $1.4 Million - $4.6 Million
622,227 New
622,227 $4.23 Million
Q2 2022

Aug 11, 2022

SELL
$0.76 - $2.64 $24,251 - $84,242
-31,910 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$1.48 - $6.22 $30,347 - $127,541
20,505 Added 179.79%
31,910 $67,000
Q4 2021

Feb 11, 2022

SELL
$8.77 - $18.29 $107,257 - $223,686
-12,230 Reduced 51.75%
11,405 $102,000
Q3 2021

Nov 04, 2021

BUY
$13.54 - $22.06 $168,911 - $275,198
12,475 Added 111.78%
23,635 $392,000
Q2 2021

Aug 11, 2021

BUY
$14.05 - $25.04 $10,720 - $19,105
763 Added 7.34%
11,160 $232,000
Q1 2021

May 13, 2021

BUY
$16.57 - $28.65 $3,214 - $5,558
194 Added 1.9%
10,397 $194,000
Q4 2020

Feb 16, 2021

BUY
$15.44 - $24.23 $36,222 - $56,843
2,346 Added 29.86%
10,203 $224,000
Q3 2020

Nov 12, 2020

BUY
$19.43 - $35.36 $3,613 - $6,576
186 Added 2.42%
7,857 $163,000
Q2 2020

Aug 13, 2020

BUY
$29.41 - $51.23 $142,079 - $247,492
4,831 Added 170.11%
7,671 $277,000
Q1 2020

May 14, 2020

BUY
$19.54 - $55.47 $9,261 - $26,292
474 Added 20.03%
2,840 $93,000
Q4 2019

Feb 14, 2020

BUY
$10.16 - $28.14 $18,613 - $51,552
1,832 Added 343.07%
2,366 $64,000
Q3 2019

Nov 14, 2019

BUY
$8.08 - $10.99 $4,314 - $5,868
534 New
534 $5,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.